This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jain, M. R. Articles by Kalra, S. P. Search for Related Content PubMed PubMed Citation Articles by Jain, M. R. Articles by Kalra, S. P.

Evidence that Stimulation of Two Modalities of Pituitary Luteinizing Hormone Release in Ovarian Steroid-Primed Ovariectomized Rats May Involve Neuropeptide Y Y1 and Y4 Receptors¹

Departments of Physiology (M.R.J., P.S.K.) and Neuroscience (S.P., S.P.K.), University of Florida College of Medicine and University of Florida Brain Institute, Gainesville, Florida 32610

Address all correspondence and requests for reprints to: Professor Satya P. Kalra, Department of Neuroscience, University of Florida Brain Institute, University of Florida College of Medicine, P.O. Box 100244, Gainesville, Florida 32610. E-mail: skalra{at}ufbi.ufl.edu

A large body of evidence indicates that neuropeptide Y (NPY) is involved in stimulation of basal and cyclic release of hypothalamic LHRH and pituitary LH. To identify the NPY receptor subtypes that mediate the excitatory effects of NPY in these two modalities of LH release, we studied the effects of 1229U91, a selective Y1 receptor antagonist and Y4 receptor agonist, in two experimental paradigms that reproduce the two modalities of LH secretion in steroid-primed ovariectomized (OVX) rats. Rats were ovariectomized and implanted with a permanent cannula into the lateral cerebroventricle. In the first experiment, rats received estradiol benzoate (EB, 30 µg/rat) on day 5, followed 2 days later with progesterone (2 mg/rat) at 1000 h to induce an afternoon LH surge. 1229U91 (30 µg/3 µl) or vehicle (control) was injected intracerebroventricularly into these rats either once at 1300 h or twice (15 µg/injection) at 1100 and 1200 h. Blood samples were collected before progesterone injection at 1000 h and at hourly intervals from 1300–1800 h via an intrajugular cannula implanted on the previous day. In control rats, serum LH levels rose significantly at 1400 h, and these high levels were maintained until 1700 h. After two injections of 1229U91, LH levels displayed a tendency to rise at 1300–1400 h, as in controls, but thereafter, decreased rapidly below the control range. In the second experiment, the acute effect of 1229U91 on LH release was evaluated in OVX rats pretreated with EB alone. Saline alone or saline containing 1, 3, 10, or 30 µg 1229U91 was injected intracerebroventricularly at 1000 h, and the effects on LH release were analyzed at 10, 20, 30, and 60 min. 1229U91 elicited a dose-dependent stimulation of LH release, with maximal response (950% of basal levels) occurring at 10 min after the 30-µg dose; elevated levels were maintained for 1 h. Because 1229U91 is a potent Y4 agonist with some affinity for Y5 receptors, these results raised the possibility that activation of Y4/Y5 receptors by 1229U91 may augment LH release. Therefore, we examined the effects of icv administration of rat pancreatic polypeptide, a Y4-selective agonist, and [D-Trp³²]-NPY, a Y5 agonist on LH release in EB-primed rats. Rat pancreatic polypeptide (0.5–2 µg/rat) stimulated LH release in a dose-related manner, and peak levels (280% of basal levels) were seen at 10–20 min; the response evoked by a higher dose (10 µg) was smaller than that induced by 0.5 or 2 µg. [D-Trp³²]-NPY was relatively less effective, because only the highest (10-µg) dose elicited a modest stimulation (244% of basal levels). These results demonstrate that 1229U91, a Y1 antagonist and Y4 agonist, evokes two types of responses; it suppresses the protracted ovarian steroid-induced LH surge, and acutely, it also stimulates LH. These results imply that normally two different types of NPY receptors may mediate the stimulation of LH release. Because 1229U91 is a Y1 receptor antagonist, inhibition of the steroid-induced LH surge by 1229U91 suggests that Y1 receptors may mediate the cyclic release of LH. On the other hand, acute stimulation of LH by 1229U91 implies that the Y4 agonist-like activity of 1229U91 may mediate the basal release of LH and that either NPY or a yet-to-be-identified endogenous Y4 receptor agonist may activate Y4 receptors in the hypothalamus to stimulate LH release.

This article has been cited by other articles:

				L. Pinilla, R. Fernandez-Fernandez, J. Roa, J. M. Castellano, M. Tena-Sempere, and E. Aguilar Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1385 - E1392. [Abstract] [Full Text] [PDF]

				R. M. Luque, R. D. Kineman, and M. Tena-Sempere Regulation of Hypothalamic Expression of KiSS-1 and GPR54 Genes by Metabolic Factors: Analyses Using Mouse Models and a Cell Line Endocrinology, October 1, 2007; 148(10): 4601 - 4611. [Abstract] [Full Text] [PDF]

				S. Lin, E.-J. D. Lin, D. Boey, N. J. Lee, K. Slack, M. J. During, A. Sainsbury, and H. Herzog Fasting Inhibits the Growth and Reproductive Axes via Distinct Y2 and Y4 Receptor-Mediated Pathways Endocrinology, May 1, 2007; 148(5): 2056 - 2065. [Abstract] [Full Text] [PDF]

				L. Pinilla, R. Fernandez-Fernandez, E. Vigo, V. M. Navarro, J. Roa, J. M. Castellano, R. Pineda, M. Tena-Sempere, and E. Aguilar Stimulatory effect of PYY-(3-36) on gonadotropin secretion is potentiated in fasted rats Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1162 - E1171. [Abstract] [Full Text] [PDF]

				R. Fernandez-Fernandez, E. Aguilar, M. Tena-Sempere, and L. Pinilla Effects of Polypeptide YY3-36 upon Luteinizing Hormone-Releasing Hormone and Gonadotropin Secretion in Prepubertal Rats: In Vivo and in Vitro Studies Endocrinology, March 1, 2005; 146(3): 1403 - 1410. [Abstract] [Full Text] [PDF]

				I. J. Clarke, K. Backholer, and A. J. Tilbrook Y2 Receptor-Selective Agonist Delays the Estrogen-Induced Luteinizing Hormone Surge in Ovariectomized Ewes, but Y1-Receptor-Selective Agonist Stimulates Voluntary Food Intake Endocrinology, February 1, 2005; 146(2): 769 - 775. [Abstract] [Full Text] [PDF]

				R. H. Mills, R. K. Sohn, and P. E Micevych Estrogen-Induced {micro}-Opioid Receptor Internalization in the Medial Preoptic Nucleus Is Mediated via Neuropeptide Y-Y1 Receptor Activation in the Arcuate Nucleus of Female Rats J. Neurosci., January 28, 2004; 24(4): 947 - 955. [Abstract] [Full Text] [PDF]

				R. E. Campbell, K. L. Grove, and M. S. Smith Gonadotropin-Releasing Hormone Neurons Coexpress Orexin 1 Receptor Immunoreactivity and Receive Direct Contacts by Orexin Fibers Endocrinology, April 1, 2003; 144(4): 1542 - 1548. [Abstract] [Full Text] [PDF]

				R. E. Campbell, M. S. Smith, S. E. Allen, B. E. Grayson, J. M. H. ffrench-Mullen, and K. L. Grove Orexin Neurons Express a Functional Pancreatic Polypeptide Y4 Receptor J. Neurosci., February 15, 2003; 23(4): 1487 - 1497. [Abstract] [Full Text] [PDF]

				A. Sainsbury, C. Schwarzer, M. Couzens, A. Jenkins, S. R. Oakes, C. J. Ormandy, and H. Herzog Y4 receptor knockout rescues fertility in ob/ob mice Genes & Dev., May 1, 2002; 16(9): 1077 - 1088. [Abstract] [Full Text] [PDF]

				T. Ichimaru, Y. Mori, and H. Okamura A Possible Role of Neuropeptide Y as a Mediator of Undernutrition to the Hypothalamic Gonadotropin-Releasing Hormone Pulse Generator in Goats Endocrinology, June 1, 2001; 142(6): 2489 - 2498. [Abstract] [Full Text] [PDF]